Elsevier

Brain Research

Volume 717, Issues 1–2, 22 April 1996, Pages 1-11
Brain Research

Research report
Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats

https://doi.org/10.1016/0006-8993(95)01454-3Get rights and content

Abstract

The antioxidant LY231617 has previously been shown to offer significant protection against postischemic cell death in the hippocampus and corpus striatum of rats. The present results extend this observation by demonstrating a concomitant protection against the spatial memory deficits that accompany damage to the hippocampus, as measured by the circular water maze task. These animals were further tested for changes in associative memory by employing a passive avoidance conditioning task. No deficits in passive avoidance conditioning were measured among the 4-vessel occlusion animals treated with LY231617 or vehicle. However, the intracerebroventricular injection of angiotensin IV (Ang IV) immediately prior to foot-shock conditioning improved retention of the conditioned response during the subsequent 2-day period. These results suggest that LY231617 can offer considerable protection against global ischemia-induced cell death in the hippocampus with resulting preservation of spatial memory abilities. In addition, untreated animals that suffered cell losses in the hippocampus remained capable of responding to the facilitory effect of centrally administered Ang IV on a non-spatial memory task. The hypothesized mechanisms of the protection characteristics of LY231617, and the nootropic effect of Ang IV, are discussed.

References (73)

  • E.D. Hall et al.

    Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation

    Free Rad. Biol. Med.

    (1989)
  • N.C. Hall et al.

    Ischemia/reperfusion-induced changes in membrane proteins and lipids of gerbil cortical synaptosomes

    Neuroscience

    (1995)
  • H. Hara et al.

    Protective effect of α-tocopherol on ischemic neuronal damage in the gerbil hippocamus

    Brain Res.

    (1990)
  • J.W. Harding et al.

    Identification of an AII (3–8) [AIV] binding site in guinea pig hippocampus

    Brain Res.

    (1992)
  • H. Kato et al.

    Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects

    Brain Res.

    (1991)
  • T. Kirino

    Delayed neuronal death in the gerbil hippocampus following ischemia

    Brain Res.

    (1982)
  • K.C. Liang et al.

    Post-training amygdaloid lesions impair retention of an inhibitory avoidance response

    Behav. Brain Res.

    (1982)
  • R.K. McNamara et al.

    Limbic seizures, but not kindling, reversibly impair place learning in the Morris water maze

    Behav. Brain Res.

    (1992)
  • R.K. McNamara et al.

    The neuropharmacological and neurochemical basis of place learning in the Morris water maze

    Brain Res. Rev.

    (1993)
  • R.G. Morris

    Spatial localization does not require the presence of local cues

    Learn. Motiv.

    (1981)
  • N. Nakata et al.

    Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil

    Brain Res.

    (1992)
  • N. Ogawa et al.

    Post-ischemic administration of bifemelane hydrochloride prohibits ischemia-induced depletion of the muscarinic M1-receptor and its mRNA in the gerbil hippocampus

    Brain Res.

    (1992)
  • R.A. Prado-Alcala et al.

    Learning deficits produced by chronic and reversible lesions of the corpus striatum in rats

    Physiol. Behav.

    (1975)
  • R. Schmidt-Kastner et al.

    Selective vulnerability of the hippocampus in brain ischemia

    Neuroscience

    (1991)
  • G.N. Swanson et al.

    Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin for a receptor

    Regul. Pept.

    (1992)
  • J.W. Wright et al.

    The angiotensin IV system: functional implications

    Front. Neuroendocrinol.

    (1995)
  • J.W. Wright et al.

    Angiotensin II(3–8) [ANG IV] hippocampal binding: potential role in the facilitation of memory

    Brain Res. Bull.

    (1993)
  • T. Araki et al.

    Selective neuronal vulnerability following transient cerebral ischemia in the gerbil: distribution and time course

    Acta Neurol. Scand.

    (1989)
  • J.S. Beckman et al.

    Evidence for a role of oxygen radicals in cerebral ischemic injury

  • K.P. Berry et al.

    Protection against postischemic mortality and neuronal necrosis in gerbils by the 21-aminosteroid U74006F, a potent inhibitor of lipid peroxidation

  • C. Bromont et al.

    Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats

    Stroke

    (1989)
  • J.J. Caronna

    Diagnosis, prognosis and treatment of hypoxic coma

  • D.W. Choi

    Methods for antagonizing glutamate neurotoxicity

    Cerebrovasc. Brain Metab. Rev.

    (1990)
  • D.W. Choi

    Calcium and excitotoxic neuronal injury

    Ann. New York Acad. Sci.

    (1994)
  • J.A. Clemens et al.

    LY178002 reduces brain damage after transient global forebrain ischemia

    Stroke

    (1991)
  • J.A. Clemens et al.

    Cell loss due to ischemia

  • Cited by (63)

    • Cognitive benefits of angiotensin IV and angiotensin-(1–7): A systematic review of experimental studies

      2018, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Thus, i.c.v. treatment is potentially more effective given that it produces more global effects due to diffusion, is easier to perform consistently among animals, and can be done in larger doses. Further, in rats, Ang IV appears to exert beneficial effects when given 5–15 min prior to learning (Wright et al., 1996; Braszko et al., 1988), immediately after learning (Golding et al., 2010; Tchekalarova et al., 2001aa,b), or 5–30 min prior to testing (Braszko et al., 2006; Paris et al., 2013; Wright et al., 1993). However, the Kerr et al. (2005) study administered Ang IV some 30, 90, and 180 min following training, which may have been simultaneously outside the optimal window for Ang IV to exert its hypothesized consolidation-enhancing effects around the time of training, as well as too far away from the testing time for its recognition-enhancing effects.

    • The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases

      2015, Progress in Neurobiology
      Citation Excerpt :

      The AngIV analog, Nle1-AngIV, has shown promise in overcoming the memory impairments evidenced by several dementia animal models. Treatment with Nle1-AngIV reverses memory deficits due to: (1) application of the cholinergic muscarinic receptor antagonist scopolamine (Pederson et al., 2001); (2) kainic acid-induced lesions of the hippocampus (Stubley-Weatherly et al., 1996); (3) perforant path knife-cuts (Wright et al., 1999); (4) ischemia resulting from transient four-vessel occlusion (Wright et al., 1996b); and (5) embolic stroke due to carotid artery injection of microspheres (Faure et al., 2006). Consistent with these behavioral results, brain binding sites for [125I] AngIV have been autoradiographically localized in structures known to mediate cognitive processing including the neocortex, hippocampus, and basal nucleus of Meynert (Chai et al., 2000; Harding et al., 1992; Wright and Harding, 2009).

    • Central administration of angiotensin IV rapidly enhances novel object recognition among mice

      2013, Neuropharmacology
      Citation Excerpt :

      Consistent with this, central administration of Ang IV induced cognitive improvements equivalent to Ang II in rats (Braszko et al., 1988), and the blockade of AT4 receptors produced deficits in spatial learning (Wilson et al., 2009; Wright et al., 1999). Agonism of AT4 receptors has been reported to promote hippocampal long-term potentiation (LTP; Kramár et al., 2001; Wayner et al., 2001), spatial learning (Lee et al., 2004; Wright et al., 1999), and the restoration of spatial cognitive function following a variety of central insults (Stubley-Weatherly et al., 1996; Wright et al., 1996, 1999; Pederson et al., 2001). In the present investigation, we assessed the dose–response relationship of Ang IV-enhanced learning and memory using a truncated version of the novel object recognition task.

    • Brain renin-angiotensin-A new look at an old system

      2011, Progress in Neurobiology
      Citation Excerpt :

      A number of studies indicate that AngIV, and AngIV analogues such as Nle1-AngIV, can facilitate long-term potentiation, learning, and memory consolidation (Albiston et al., 2004a,b; Braszko et al., 1988; Kramár et al., 2001; Wright et al., 1999). Most importantly studies using various dementia models to test the efficacy of Nle1-AngIV have demonstrated that acute application reversed deficits initiated by: (1) treatment with scopolamine (Pederson et al., 2001); (2) kainic acid injections into the hippocampus (Stubley-Weatherly et al., 1996); (3) perforant path cuts (Wright et al., 1999); and (4) ischemia resulting from transient four vessel occlusion (Wright et al., 1996b). Consistent with these behavioral and electrophysiological results, brain binding sites for [125I]-AngIV have been autoradiographically localized in structures that mediate cognitive processing including the neocortex, hippocampus, and basal nucleus of Meynert (Chai et al., 2000; Harding et al., 1992; Wright and Harding, 2009).

    View all citing articles on Scopus
    View full text